title: [A comparative study of the inoculation properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8- to 15-year-old children].
abstract: This study was carried out to compare reactogenicity, immunogenicity, and efficacy of live attenuated and inactivated influenza vaccines prepared from influenza A/Philippines/2/82-like virus strains. Schoolchildren of a boarding school of Moscow were randomly divided into three groups: (1) vaccinated with a live attenuated vaccine, (2) vaccinated with inactivated influenza vaccine, and (3) given placebo. Both vaccines were well tolerated by the children, with practically no severe general or local reactions. The inactivated vaccine was found to be superior to the live one in its capacity to stimulate humoral immunity studied by HI, EIA, and microneutralization tests. In 69.7% of the children given the inactivated vaccine, seroconversion to the vaccine strain was detected by two or three methods of antibody titration used. Only 35.4% seroconversions were demonstrated in children immunized with the live influenza vaccine. Enzyme immunoassay was found to be a more sensitive but less specific method for antibody titration as compared with HI test whereas microneutralization proved to be more specific but less sensitive for titration of antibodies to influenza A (H3N2) viruses.
authors.forename: A N
authors.initials: AN
authors.lastname: Slepushkin
authors.forename: N P
authors.initials: NP
authors.lastname: Obrosova-Serova
authors.forename: E I
authors.initials: EI
authors.lastname: Burtseva
authors.forename: E A
authors.initials: EA
authors.lastname: Govorkova
authors.forename: L G
authors.initials: LG
authors.lastname: Rudenko
authors.forename: R V
authors.initials: RV
authors.lastname: Vartanian
authors.forename: A I
authors.initials: AI
authors.lastname: Vereshchinskiĭ
authors.forename: M D
authors.initials: MD
authors.lastname: Musina
authors.forename: N I
authors.initials: NI
authors.lastname: Lonskaia
authors.forename: L A
authors.initials: LA
authors.lastname: Zazimko
mesh_terms: D000293:Adolescent; D000914:Antibodies, Viral / Q000097:blood; D002648:Child; D004196:Disease Outbreaks / Q000517:prevention & control; D006801:Humans; D007252:Influenza Vaccines / Q000009:adverse effects / Q000276:immunology*; D007251:Influenza, Human / Q000517:prevention & control; D007391:International Cooperation; D009031:Moscow; D009975:Orthomyxoviridae / Q000276:immunology; D014481:United States; D015164:Vaccines, Inactivated / Q000009:adverse effects / Q000276:immunology; D014614:Vaccines, Synthetic / Q000009:adverse effects / Q000276:immunology
chemical_list: D000914:Antibodies, Viral; D007252:Influenza Vaccines; D015164:Vaccines, Inactivated; D014614:Vaccines, Synthetic
vernacular_title: Sravnitel'noe izuchenie privivochnykh svoĭstv zhivoĭ rekombinantnoĭ i inaktivirovannoĭ grippoznykh vaktsin iz shtamma A/Filippiny/2/82 (H3N2) u deteĭ 8--15 let.